1. Home
  2. XLO vs XOS Comparison

XLO vs XOS Comparison

Compare XLO & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.49

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Logo Xos Inc.

XOS

Xos Inc.

HOLD

Current Price

$2.90

Market Cap

41.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
XOS
Founded
2016
2016
Country
United States
United States
Employees
N/A
101
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
41.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
XLO
XOS
Price
$8.49
$2.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.6K
★ 155.3K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 59.49
EPS
★ N/A
N/A
Revenue
$43,766,000.00
★ $45,992,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.30
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 589.88
N/A
52 Week Low
$0.46
$1.60
52 Week High
$25.17
$8.27

Technical Indicators

Market Signals
Indicator
XLO
XOS
Relative Strength Index (RSI) 43.16 46.25
Support Level $8.52 $1.90
Resistance Level $8.80 $3.07
Average True Range (ATR) 0.33 0.27
MACD -0.03 -0.03
Stochastic Oscillator 22.16 26.29

Price Performance

Historical Comparison
XLO
XOS

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

Share on Social Networks: